These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17917628)

  • 21. The clinical and biochemical effects of two combination oral contraceptive agents.
    Sapire KE; Berger GM; Maritz JS
    S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women.
    Merki-Feld GS; Rosselli M; Dubey RK; Jäger AW; Keller PJ
    Contraception; 2002 Mar; 65(3):231-6. PubMed ID: 11929645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.
    Boonyarangkul A; Taneepanichskul S
    J Med Assoc Thai; 2007 Sep; 90(9):1715-9. PubMed ID: 17957909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
    Luoma PV; Heikkinen JE; Ehnholm C; Ylöstalo PR
    Eur J Clin Pharmacol; 1987; 31(5):563-7. PubMed ID: 3104057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    Bird ST; Delaney JA; Etminan M; Brophy JM; Hartzema AG
    J Thromb Haemost; 2013 Jun; 11(6):1059-68. PubMed ID: 23574590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW; Fisher AC; Hall N; Shangold GA
    J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Ishak R; Loh Chooi Khim
    Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 40. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
    Tuppurainen M; Klimscheffskij R; Venhola M; Dieben TO
    Contraception; 2004 May; 69(5):389-94. PubMed ID: 15105061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.